Valuation Unichem Laboratories Limited NSE India S.E.
Stocks
UNICHEMLAB
INE351A01035
Pharmaceuticals
|
Market Closed -
NSE India S.E.
07:05:10 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 573.20 INR | +6.39% |
|
+10.43% | +29.73% |
Company Valuation: Unichem Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 21,776 | 18,330 | 20,351 | 34,393 | 48,777 | 20,682 |
| Change | - | -15.83% | 11.02% | 69% | 41.82% | -57.6% |
| Enterprise Value (EV) 1 | 19,829 | 18,094 | 21,638 | 35,346 | 52,479 | 22,788 |
| Change | - | -8.75% | 19.59% | 63.35% | 48.47% | -56.58% |
| P/E | 63.4x | 55.6x | -10.1x | -48.8x | 35.6x | 8.19x |
| PBR | 0.85x | 0.7x | 0.84x | 1.46x | 1.99x | 0.76x |
| PEG | - | -13.88x | 0x | 0.7x | -0x | 0.1x |
| Capitalization / Revenue | 1.76x | 1.44x | 1.52x | 2.02x | 2.31x | 0.94x |
| EV / Revenue | 1.61x | 1.42x | 1.61x | 2.07x | 2.49x | 1.03x |
| EV / EBITDA | 23.6x | 24.2x | -45.1x | 37.5x | 20.4x | 12.6x |
| EV / EBIT | 273x | -166x | -13.9x | -272x | 37.4x | 35.8x |
| EV / FCF | -9.72x | -5.18x | -29.2x | 64.1x | -23.3x | -20.8x |
| FCF Yield | -10.3% | -19.3% | -3.42% | 1.56% | -4.3% | -4.8% |
| Dividend per Share 2 | 4 | 4 | - | - | - | - |
| Rate of return | 1.29% | 1.54% | - | - | - | - |
| EPS 2 | 4.875 | 4.68 | -28.72 | -10.01 | 19.47 | 35.85 |
| Distribution rate | 82% | 85.5% | - | - | - | - |
| Net sales 1 | 12,351 | 12,698 | 13,430 | 17,049 | 21,110 | 22,018 |
| EBITDA 1 | 838.6 | 747 | -480.2 | 943.7 | 2,577 | 1,815 |
| EBIT 1 | 72.76 | -109 | -1,556 | -129.9 | 1,403 | 635.7 |
| Net income 1 | 343.2 | 330.6 | -2,022 | -704.7 | 1,375 | 2,528 |
| Net Debt 1 | -1,948 | -236.2 | 1,288 | 952.6 | 3,702 | 2,107 |
| Reference price 2 | 309.30 | 260.35 | 289.05 | 488.50 | 692.80 | 293.75 |
| Nbr of stocks (in thousands) | 70,406 | 70,406 | 70,406 | 70,406 | 70,406 | 70,406 |
| Announcement Date | 7/2/21 | 7/12/22 | 8/30/23 | 7/11/24 | 7/4/25 | 7/3/26 |
1INR in Million2INR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 33.27x | 12.06x | 24.51x | 0.59% | 1,043B | ||
| 29.94x | 6.66x | 18.64x | 2% | 649B | ||
| 33.54x | 7.85x | 16.21x | 2.59% | 469B | ||
| 19.72x | 4.82x | 11.95x | 2.75% | 355B | ||
| 20.01x | 5.21x | 12.94x | 3.07% | 270B | ||
| 21.55x | 4.46x | 12.7x | 1.98% | 262B | ||
| 26.04x | 6.76x | 12.04x | 2.46% | 222B | ||
| -46.18x | 6.71x | 26.22x | 2.16% | 189B | ||
| 11.59x | 4.21x | 8.76x | 4.34% | 175B | ||
| Average | 16.61x | 6.53x | 16.00x | 2.44% | 403.67B | |
| Weighted average by Cap. | 23.93x | 7.81x | 18.02x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- UNICHEMLAB Stock
- UNICHEMLAB Stock
- Valuation Unichem Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















